- Revlimid with Exjade
- withdrawal from cyclosporine?
- Results and side effects from Vidaza
- danazol and zenapax (daclizumab)
- Exjade and liver inflammation
- Vidaza disaster
- Giving Exjade a 2nd try
- Started Revlimid - good results
- Dacogen
- Neulasta
- ATG
- vidaza and itching
- Counts not recovering on Dacogen
- dacogen vs vidaza
- Re-starting Dacogen
- Did cyclosporine cause my lymphoma?
- Revlimid not holding up counts
- Tell me about Campath please
- After Revlimid
- Swelling of the face with Revlimid
- Dacogen and kidney problems
- Dacogen info seen on NOVA
- Romiplostim (AMG 531) for low platelets
- Low SerumEPO associated with good Aranesp/Procrit/Epogen response
- Eltrombopag can decrease leukemia cell proloferation
- Revlimid after Dacogen
- cGVHD
- Romiplostim Study Results Announced
- Vidaza in Europe at last
- Aranesp
- Neupogen - Effects on Blood Tests?
- Aranest
- Aranesp
- solarimus
- Bad news about AMG 531/Romiplostim/Nplate
- Yahoo! One step closer to new platelet drug
- Which patients will respond to Revlimid ?
- How Dacogen is working
- Vidaza and MGCD0103
- News about Zolinza and similar drugs
- Another delay with new platelet drug
- How long til Aranesp works?
- Info from FDA meeting about Nplate and MDS
- Decrease in Cyclosporine dose
- MDS - Vidaza tendinitis?
- ExJade-side effects?
- Anadrol for AA?
- TELINTRA in Phase II trials
- Gimotecan
- Eltrombopag for low platelets will perhaps be approved June 19
- We are moving ahead with Anadrol
- Updated warning for Aranesp and similar drugs
- FDA Medwatch Warning on CellCept, have you seen this yet?
- Vidaza better than Dacogen?
- MDS treatment interesting video
- Epival
- Need info regarding Vidaza treatment
- idarubensin ara-c
- aranesp for mds
- New drug, Ceplene, could prevent ralapse of AML
- Revlimid not approved for MDS in EU due to risk for AML
- treatment for low wbcs?
- Side Effects of Revlimid
- Website with Adverse effects data
- Lytoxan chemotherapy treatment desperately sought
- New drug - MGCD0103 - can give heart symptoms
- Pulling Procrit
- Vidaza receives expanded FDA approval
- FDA approval for drug for low platelets
- About treatment with Revlimid (lenalidomide) and EPO
- New drug - sapacitabine - in phase II trial
- Fatigue with Aransep?
- New drug, ON 01910. Na, for MDS in Phase I trial
- Vitamin C may blunt effect of chemotherapy
- Clinical protocols
- Exjade
- Has anyone been on Dacogen plus valproic acid?
- Vidaza soon in EU
- Starting on Dacogen
- Leftover Cyclosporine
- Promacta for low platelets approved by FDA
- Promacta (Eltrombopag) and bone marrow
- 2nd round of dacogen
- Vidaza in EU at last!
- The Doctor Came In Smileing Ear To Ear!
- Nellie's Journey on Vidaza
- Revlimid response, low platelets and transfusion independence
- Sapacitabine a new drug for MDS?
- Exjade and counts
- Nausea and chemo Aloxi better than Zofran
- Problems with Vidaza
- Problems with Procrit
- Revlimid and low risk/high risk MDS
- kidney problems with cyclosporine
- For Helen about Telintra
- Imuran vs. generic?
- Report from the MDS Foundation Symposium
- ? reaction to midazolam
- Revlimid
- Cyclosporine + fluconazole